Health Care

Stocks are sagging Friday after weak economic data from China has investors worrying about the global economy again.

Antelliq Group makes digital identification products for animals.

The Nasdaq turned negative for the week, joining the Dow and S&P 500.

New York state is suing two of the nation's largest retailers and a third company for importing and selling children's toys with lead levels up to 10 times higher than federal limits.

Toyota is recalling nearly 143,000 SUVs and pickups worldwide to fix air bag and brake problems.

The eye screening program in Thailand follows a similar Google program in India.

Toyota is recalling about 70,000 Toyota and Lexus brand vehicles in North America to replace air bag inflators that could explode and hurl shrapnel at drivers and passengers.

Christopher Clough has pleaded not guilty to receiving kickbacks.

However, J&J said Tremfya was not superior to Cosentyx in demonstrating quicker effectiveness.

Monika Krcova did not want to follow the official guidelines and remain in the Slovakian hospital for four days after her third baby's birth.

Generic drugs account for the majority of prescriptions filled in the U.S.

The industry veteran will be tasked with helping the drug company revive sales, recover from a disappointing deal.

A generic drugmaker plans to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.

Health care and business services led U.S. job gains in November, a month that saw slower hiring overall.

One of the world's largest tobacco companies is now in the budding marijuana business.

Nissan, the Japanese automaker under scrutiny after its former chairman Carlos Ghosn was arrested on suspicion of financial misconduct, is recalling 150,000 vehicles spanning 11 models in Japan for dubious inspections for brakes and steering.

___ Stocks plunge again as Huawei arrest renews China tensions NEW YORK (AP) — U.S. stocks clawed most of their way back from a deep slide Thursday that at one point had wiped out the market's gains for the year.

A pharmaceutical company has agreed to pay $360 million to resolve allegations that it used a charitable foundation to pay kickbacks to Medicare patients.